SYNB
Putnam BioRevolution ETF · PSE
- Category Equity
- Expense Ratio 0.7%
- Listing Date Sep 30, 2022
- Volume 47.0
- Market Cap (AUM) $5.35M
Performance
+3.15%
1W
+0.61%
1M
+3.7%
3M
+18.18%
6M
+4.96%
YTD
+12.16%
1Y
Top Holdings
-
Name
Symbol%Assets
- Thermo Fisher Scientific Inc.TMO7.87%
- Danaher CorporationDHR7.24%
- NVIDIA CorporationNVDA6.67%
- Alphabet Inc. Class AGOOGL6.23%
- Bio-Rad Laboratories, Inc. Class ABIO5.34%
- Corteva IncCTVA4.52%
- Novonesis A/S (Novozymes A/S) Unsponsored ADR Class BNVZMY4.39%
- AbbVie, Inc.ABBV3.95%
- Ascendis Pharma A/S Sponsored ADRASND3.85%
- Eli Lilly and CompanyLLY3.74%
Technical Analysis of SYNB 2024-05-03
Overview:
In analyzing the technical indicators for SYNB over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement. By examining these key aspects, we aim to offer valuable insights and predictions for the upcoming days.
Trend Indicators...
Recent News & Updates
Page 1 of 1
previousnext